hydroxychloroquine has been researched along with Asymptomatic Conditions in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Novel coronavirus disease 2019 is rapidly spreading throughout the New York metropolitan area since its first reported case on March 1, 2020." | 1.56 | Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. ( Andrikopoulou, M; Aubey, J; Baptiste, C; Bernstein, K; Breslin, N; D'Alton, ME; Friedman, AM; Fuchs, K; Goffman, D; Gyamfi-Bannerman, C; Landau, R; Martinez, R; Miller, R; Moroz, L; Mourad, M; Purisch, S; Ring, L; Rupley, D; Sheen, JJ; Simpson, LL; Sutton, D; Wapner, R; Zork, N, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breslin, N | 1 |
| Baptiste, C | 1 |
| Gyamfi-Bannerman, C | 1 |
| Miller, R | 1 |
| Martinez, R | 1 |
| Bernstein, K | 1 |
| Ring, L | 1 |
| Landau, R | 1 |
| Purisch, S | 1 |
| Friedman, AM | 1 |
| Fuchs, K | 1 |
| Sutton, D | 1 |
| Andrikopoulou, M | 1 |
| Rupley, D | 1 |
| Sheen, JJ | 1 |
| Aubey, J | 1 |
| Zork, N | 1 |
| Moroz, L | 1 |
| Mourad, M | 1 |
| Wapner, R | 1 |
| Simpson, LL | 1 |
| D'Alton, ME | 1 |
| Goffman, D | 1 |
| Gegúndez-Fernández, JA | 1 |
| Zarranz-Ventura, J | 1 |
| Garay-Aramburu, G | 1 |
| Muñoz-Negrete, FJ | 1 |
| Mendicute Del Barrio, J | 1 |
| Pablo-Júlvez, L | 1 |
| García-Delpech, S | 1 |
| López-Alemany, A | 1 |
| Arnalich-Montiel, F | 1 |
| Cordero-Coma, M | 1 |
| Cárceles, JA | 1 |
| Miao, H | 1 |
| Li, H | 1 |
| Yao, Y | 1 |
| Wu, M | 1 |
| Lu, C | 1 |
| Wang, J | 1 |
| Tian, M | 1 |
| Li, Y | 1 |
| Luo, P | 1 |
| Gu, J | 1 |
| Yuan, B | 1 |
| Wang, S | 1 |
| Zhao, X | 1 |
| Gan, W | 1 |
| Zhao, D | 1 |
| Clancy, RM | 1 |
| Markham, AJ | 1 |
| Buyon, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Single Center, Randomized, Controlled Trial of the Safety and Efficacy of Progesterone for the Treatment of COVID-19 in Hospitalized Men[NCT04365127] | Phase 1 | 40 participants (Actual) | Interventional | 2020-04-27 | Completed | ||
| Valuation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19[NCT04598347] | 225 participants (Anticipated) | Observational [Patient Registry] | 2020-08-08 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for hydroxychloroquine and Asymptomatic Conditions
| Article | Year |
|---|---|
Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
Topics: Antimalarials; Asymptomatic Diseases; Betacoronavirus; Blood Safety; Chloroquine; Contact Lenses; Co | 2020 |
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Biomarke | 2020 |
Endosomal Toll-like receptors in clinically overt and silent autoimmunity.
Topics: Animals; Asymptomatic Diseases; Autoantibodies; Autoimmunity; Endosomes; Heart Block; Humans; Hydrox | 2016 |
1 other study available for hydroxychloroquine and Asymptomatic Conditions
| Article | Year |
|---|---|
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Topics: Adult; Ambulatory Care; Anti-Bacterial Agents; Asymptomatic Diseases; Azithromycin; Carrier State; C | 2020 |